Mind Medicine (MindMed) Inc. (OTCQB: MMEDF) is a neuro-pharmaceutical company that discovers, develops, and deploys psychedelic inspired medicines to offer solutions to address mental health issues including anxiety, addiction, and depression. CEO, JR Rahn, provides a perspective on how the current social and economic climate correlates with mental health and Mind Med's mission to provide therapeutic benefits of psychedelics to resolve mental illness.